BVF PARTNERS L P/IL Insider Trading $GLYC GLYCOMIMETICS INC
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).
BVF PARTNERS L P/IL in GLYCOMIMETICS INC
Trading Symbol: GLYCIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 4,306,320 shares
Current Value: $26,957,563
Latest Transaction: Nov 03 2020
$GLYC Market Capitalization: $140.70M
$GLYC Previous Close: $6.26
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in GLYCOMIMETICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 03 2020 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.75 | 15,472 | 42,548 | 544,363 | 528.9 K to 544.4 K (+2.93 %) |
Nov 03 2020 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.75 | 250,755 | 689,576 | 3,206,195 | 3 M to 3.2 M (+8.48 %) |
Nov 03 2020 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.75 | 666,385 | 1,832,559 | 4,306,320 | 3.6 M to 4.3 M (+18.31 %) |
Nov 03 2020 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.75 | 15,472 | 42,548 | 544,363 | 528.9 K to 544.4 K (+2.93 %) |
Nov 03 2020 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.75 | 250,755 | 689,576 | 3,206,195 | 3 M to 3.2 M (+8.48 %) |
Nov 03 2020 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.75 | 666,385 | 1,832,559 | 4,306,320 | 3.6 M to 4.3 M (+18.31 %) |
Sep 09 2019 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.18 | 124,956 | 397,610 | 528,891 | 403.9 K to 528.9 K (+30.93 %) |
Sep 09 2019 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.18 | 689,834 | 2,195,052 | 2,955,440 | 2.3 M to 3 M (+30.45 %) |
Sep 09 2019 | GLYC | GLYCOMIMETICS INC | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.18 | 853,956 | 2,717,288 | 3,639,935 | 2.8 M to 3.6 M (+30.65 %) |
Page: 1